AU3257095A - Deuterium-containing pharmaceutical compositions for destroying tumors - Google Patents

Deuterium-containing pharmaceutical compositions for destroying tumors

Info

Publication number
AU3257095A
AU3257095A AU32570/95A AU3257095A AU3257095A AU 3257095 A AU3257095 A AU 3257095A AU 32570/95 A AU32570/95 A AU 32570/95A AU 3257095 A AU3257095 A AU 3257095A AU 3257095 A AU3257095 A AU 3257095A
Authority
AU
Australia
Prior art keywords
deuterium
pharmaceutical compositions
containing pharmaceutical
destroying tumors
destroying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32570/95A
Other languages
English (en)
Inventor
Albrecht Bauer
Ulrich Bogdahn
Axel Haase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3257095A publication Critical patent/AU3257095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU32570/95A 1994-08-04 1995-08-03 Deuterium-containing pharmaceutical compositions for destroying tumors Abandoned AU3257095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4427690 1994-08-04
DE19944427690 DE4427690A1 (de) 1994-08-04 1994-08-04 Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
PCT/EP1995/003100 WO1996003996A1 (de) 1994-08-04 1995-08-03 Deuterium enthaltende pharmazeutische zusammensetzung zur abtötung von tumoren

Publications (1)

Publication Number Publication Date
AU3257095A true AU3257095A (en) 1996-03-04

Family

ID=6524964

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32570/95A Abandoned AU3257095A (en) 1994-08-04 1995-08-03 Deuterium-containing pharmaceutical compositions for destroying tumors

Country Status (5)

Country Link
EP (1) EP0773784A1 (de)
AU (1) AU3257095A (de)
CA (1) CA2196671A1 (de)
DE (1) DE4427690A1 (de)
WO (1) WO1996003996A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
US7601737B2 (en) 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
DE102006049185A1 (de) * 2006-10-18 2008-04-24 Bayerl, Thomas M., Prof. Dr. Verwendung von Deuteriumdioxid zur Behandlung von hyperproliferativen Erkrankungen der Haut
DE102007031397A1 (de) * 2007-07-05 2009-01-08 D2O Bioscience Group Ltd. Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
EP2110132B1 (de) 2008-04-20 2014-01-22 D2 Bioscience Group Ltd Verwendung von Deuteriumoxid als Elastase-Inhibitor
DE102009003942A1 (de) 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges
CN105311051A (zh) 2014-05-26 2016-02-10 陈松源 具有增加抗肿瘤药物疗效的载体溶媒、制备方法及其给药途径

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002663A (en) * 1975-03-03 1977-01-11 G. D. Searle & Co. Deuterated prostaglandin analogs
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
JPS60152487A (ja) * 1984-01-18 1985-08-10 Sato Yakugaku Kenkyusho:Kk デユウテロポルフイリン誘導体及びその塩
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
GB2208798B (en) * 1987-07-20 1991-06-05 Norsk Hydro As Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative
GB8726505D0 (en) * 1987-11-12 1987-12-16 Ici Plc Naphtho(2 1-b)furan derivatives
GB8810173D0 (en) * 1988-04-29 1988-06-02 Norsk Hydro As Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer
US5032610A (en) * 1988-11-21 1991-07-16 Norsk Hydro As Activity against carcinoma and method for the treatment of carcinoma
US5135948A (en) * 1988-11-21 1992-08-04 Norsk Hydro A.S. Pharmaceutical compositions with anti-cancer activity against carcinoma and method for the treatment of carcinoma
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
GB9201275D0 (en) * 1992-01-21 1992-03-11 Norsk Hydro As New compounds
GB9214202D0 (en) * 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
NO940195L (no) * 1993-01-25 1994-07-26 Norsk Hydro As Nye forbindelser
US5382582A (en) * 1993-03-26 1995-01-17 Chan; Carcy L. Methotrexate analogs and methods of using same
DE4343838C2 (de) * 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
GB9400047D0 (en) * 1994-01-04 1994-03-02 Norsk Hydro As Pharmaceutical compositions

Also Published As

Publication number Publication date
CA2196671A1 (en) 1996-02-15
EP0773784A1 (de) 1997-05-21
DE4427690A1 (de) 1996-02-08
WO1996003996A1 (de) 1996-02-15

Similar Documents

Publication Publication Date Title
HU9601698D0 (en) Pharmaceutical composition
AU3481795A (en) Pharmaceutical compositions containing d2o
GB9519667D0 (en) Pharmaceutical composition
ZA962214B (en) Pharmaceutical composition
ZA963590B (en) Pharmaceutical composition
AU2531295A (en) Pharmaceutical composition
AU3257095A (en) Deuterium-containing pharmaceutical compositions for destroying tumors
ZA961051B (en) Pharmaceutical composition
GB9525194D0 (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
HU9602822D0 (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
HUP9602732A2 (en) Pharmaceutical composition comprising lanperisone
ZA95736B (en) Pharmaceutical composition
AUPN007494A0 (en) Pharmaceutical composition
AUPM841894A0 (en) Pharmaceutical composition
AUPM341094A0 (en) Pharmaceutical composition
AU723097C (en) Pharmaceutical composition
GB9505368D0 (en) Pharmaceutical composition
GB9507037D0 (en) Pharmaceutical composition
HU9903430D0 (en) Pharmaceutical composition
GB9519748D0 (en) Pharmaceutical composition
GB9517063D0 (en) Pharmaceutical composition